Three advocacy groups are pushing the Biden administration to use federal laws to license patents on a cancer treatment to outside manufacturers in order to produce lower-cost versions.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
